Merry Christmas and a Happy New Year - 22.12.2015

Merry Christmas and a Happy New Year

The IMA over Christmas and New Year - 11.12.2015

The Icelandic Medicines Agency will be closed 24, 25 and 31 December 2015 and January 1 2016.

New application form for classification - 15.10.2015

The Icelandic Medicines Agency has updated the application form for classification.

The Icelandic Medicines Agency is closed due to Union strike - 14.10.2015

From Thursday the 15th of October until Tuesday the 20th of October The Icelandic Medicines Agency is closed. The Agency will reopen Wednesday 21st of October.

Receipt of clinical trial applications (CTA) in 2015 - 30.9.2015

Deadline for submitting a clinical trial application (CTA) in 2015 is 11 December.

IMA closed Friday 25 September - 24.9.2015

The Icelandic Medicines Agency will be closed Friday 25 September, due to an annual Out-of-office Workshop by staff.

Information to the Marketing Authorisation Holder – Hydroxyzine hydrochloride/Atarax - 13.4.2015

Referral Art. 31, EMEA/H/A-31/1400 regarding Hydroxyzine hydrochloride/Atarax is finished

.

Receipt of clinical trial applications (CTA) summer 2015 - 27.2.2015

Due to summer holiday the Icelandic Medicines Agency (IMA) will not confirm receipt of clinical trial applications from 15 June to 15 August 2015.

The Icelandic Medicines Agency (IMA) introduces electronic signatures - 20.2.2015

An electronic signature leads to more effective resolution of errands, less use of paper and postal cost.

New Executive Director of IMA - 2.2.2015

Rúna Hauksdóttir is the new Executive Director of IMA as from 1 February 2015.


Information to the Marketing Authorisation Holder - Nasonex - 28.1.2015

Referral Art. 30, EMEA/H/A-30/1375 regarding  Nasonex and associated names was finalised 20 January 2015.

Information to the Marketing Authorisation Holder – Colistimethate Alvogen - 8.1.2015

Referral Art. 31, EMEA/H/A-31/1383 regarding Colistimethate Alvogen 1 milljón a.e. og 2 milljónir a.e. stungulyfs-/innrennslisstofn, lausn was finalised 17 December 2014.

See All